169 related articles for article (PubMed ID: 27793228)
1. Microbes and Oxytocin: Benefits for Host Physiology and Behavior.
Erdman SE; Poutahidis T
Int Rev Neurobiol; 2016; 131():91-126. PubMed ID: 27793228
[TBL] [Abstract][Full Text] [Related]
2. The Effect of
Dooling SW; Sgritta M; Wang IC; Duque ALRF; Costa-Mattioli M
mSystems; 2022 Dec; 7(6):e0035822. PubMed ID: 36286493
[TBL] [Abstract][Full Text] [Related]
3. Metabolic role of lactobacilli in weight modification in humans and animals.
Drissi F; Raoult D; Merhej V
Microb Pathog; 2017 May; 106():182-194. PubMed ID: 27033001
[TBL] [Abstract][Full Text] [Related]
4. Modulation of Gut Microbiota-Brain Axis by Probiotics, Prebiotics, and Diet.
Liu X; Cao S; Zhang X
J Agric Food Chem; 2015 Sep; 63(36):7885-95. PubMed ID: 26306709
[TBL] [Abstract][Full Text] [Related]
5. Tolerogenic probiotics: potential immunoregulators in Systemic Lupus Erythematosus.
Esmaeili SA; Mahmoudi M; Momtazi AA; Sahebkar A; Doulabi H; Rastin M
J Cell Physiol; 2017 Aug; 232(8):1994-2007. PubMed ID: 27996081
[TBL] [Abstract][Full Text] [Related]
6. Probiotics, prebiotics, and synbiotics.
de Vrese M; Schrezenmeir J
Adv Biochem Eng Biotechnol; 2008; 111():1-66. PubMed ID: 18461293
[TBL] [Abstract][Full Text] [Related]
7. Understanding the role of gut microbes and probiotics in obesity: how far are we?
Sanz Y; Rastmanesh R; Agostoni C
Pharmacol Res; 2013 Mar; 69(1):144-55. PubMed ID: 23147032
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota in obesity and metabolic disorders.
Sanz Y; Santacruz A; Gauffin P
Proc Nutr Soc; 2010 Aug; 69(3):434-41. PubMed ID: 20540826
[TBL] [Abstract][Full Text] [Related]
9. Microbial stimulation of oxytocin release from the intestinal epithelium via secretin signaling.
Danhof HA; Lee J; Thapa A; Britton RA; Di Rienzi SC
Gut Microbes; 2023 Dec; 15(2):2256043. PubMed ID: 37698879
[TBL] [Abstract][Full Text] [Related]
10. The Role of Probiotics on the Microbiota: Effect on Obesity.
Nova E; Pérez de Heredia F; Gómez-Martínez S; Marcos A
Nutr Clin Pract; 2016 Jun; 31(3):387-400. PubMed ID: 26869611
[TBL] [Abstract][Full Text] [Related]
11. Probiotics: Interaction with gut microbiome and antiobesity potential.
Arora T; Singh S; Sharma RK
Nutrition; 2013 Apr; 29(4):591-6. PubMed ID: 23287068
[TBL] [Abstract][Full Text] [Related]
12. Microbial lysate upregulates host oxytocin.
Varian BJ; Poutahidis T; DiBenedictis BT; Levkovich T; Ibrahim Y; Didyk E; Shikhman L; Cheung HK; Hardas A; Ricciardi CE; Kolandaivelu K; Veenema AH; Alm EJ; Erdman SE
Brain Behav Immun; 2017 Mar; 61():36-49. PubMed ID: 27825953
[TBL] [Abstract][Full Text] [Related]
13. Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.
Miele L; Giorgio V; Alberelli MA; De Candia E; Gasbarrini A; Grieco A
Curr Cardiol Rep; 2015 Dec; 17(12):120. PubMed ID: 26497040
[TBL] [Abstract][Full Text] [Related]
14. Interaction between obesity and the gut microbiota: relevance in nutrition.
Delzenne NM; Cani PD
Annu Rev Nutr; 2011 Aug; 31():15-31. PubMed ID: 21568707
[TBL] [Abstract][Full Text] [Related]
15. Probiotics.
Gupta V; Garg R
Indian J Med Microbiol; 2009; 27(3):202-9. PubMed ID: 19584499
[TBL] [Abstract][Full Text] [Related]
16. The microbiome and probiotics in childhood.
Hsieh MH
Semin Reprod Med; 2014 Jan; 32(1):23-7. PubMed ID: 24390917
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the role of probiotics in human inflammation and gut health.
Rupa P; Mine Y
J Agric Food Chem; 2012 Aug; 60(34):8249-56. PubMed ID: 22897745
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.
Kootte RS; Vrieze A; Holleman F; Dallinga-Thie GM; Zoetendal EG; de Vos WM; Groen AK; Hoekstra JB; Stroes ES; Nieuwdorp M
Diabetes Obes Metab; 2012 Feb; 14(2):112-20. PubMed ID: 21812894
[TBL] [Abstract][Full Text] [Related]
19. Microbial symbionts accelerate wound healing via the neuropeptide hormone oxytocin.
Poutahidis T; Kearney SM; Levkovich T; Qi P; Varian BJ; Lakritz JR; Ibrahim YM; Chatzigiagkos A; Alm EJ; Erdman SE
PLoS One; 2013; 8(10):e78898. PubMed ID: 24205344
[TBL] [Abstract][Full Text] [Related]
20. The quest for probiotic effector molecules--unraveling strain specificity at the molecular level.
Lee IC; Tomita S; Kleerebezem M; Bron PA
Pharmacol Res; 2013 Mar; 69(1):61-74. PubMed ID: 23059538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
